Related Experiment Videos
Estradiol induces DNA fragmentation in a human endometrial adenocarcinoma with estradiol-inhibited growth phenotype
1Research Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden. Lena.Karlsson@ss.gu.se
Abstract:
A moderately differentiated human endometrial adenocarcinoma heterotransplanted into nude mice was investigated for morphological and molecular changes in the tumours after treating the animals with estradiol. The tumour growth was previously characterised as estradiol-independent but responsive (inhibited) without any changes in cell proliferation. In response to hormonal treatment rather the cell loss factor increased. In this experiment tumours influenced by estradiol were investigated at different time-points after treatment by an in situ labelling technique to detect cells undergoing DNA fragmentation as a sign of apoptosis. Expression of the apoptosis related protein bcl-2 was evaluated by Western blotting. Tumours from animals treated with estradiol showed an increase in tumour volume doubling time from 5.4 days to 16 days compared to control tumours. Histologically, tumours influenced by estradiol were better differentiated than control tumours and showed a significant increase in cells staining positively with the in situ apoptosis detection technique. A parallel time dependent decreased expression of bcl-2 protein was observed. These results confirm our previous findings where estradiol influenced the cell loss factor without changes in the growth fraction, indicating increased apoptotic activity in response to hormonal treatment.
Insights
Estradiol treatment inhibited endometrial adenocarcinoma growth in mice by increasing apoptosis, not by altering cell proliferation. This hormonal effect led to better-differentiated tumors and reduced bcl-2 protein expression.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Endometrial adenocarcinoma growth can be influenced by hormones.
- Previous studies indicated estradiol inhibits tumor growth via increased cell loss, not proliferation changes.
Purpose of the Study:
- To investigate morphological and molecular changes in endometrial adenocarcinoma tumors after estradiol treatment.
- To detect apoptosis and evaluate bcl-2 protein expression in response to estradiol.
Main Methods:
- Heterotransplantation of human endometrial adenocarcinoma into nude mice.
- In situ labeling technique to detect DNA fragmentation (apoptosis).
- Western blotting to evaluate bcl-2 protein expression.
Main Results:
- Estradiol treatment increased tumor volume doubling time from 5.4 to 16 days.
- Histological analysis revealed better tumor differentiation and increased apoptosis.
- A time-dependent decrease in bcl-2 protein expression was observed.
Conclusions:
- Estradiol enhances apoptosis in endometrial adenocarcinoma, leading to slower tumor growth and improved differentiation.
- The findings support estradiol's role in increasing the cell loss factor through apoptotic activity.